[Skip to Navigation]
Invited Commentary
October 7, 2020

Clinical Decision Support in Statin Prescription—What We Can Learn From a Negative Outcome

Author Affiliations
  • 1Healthcare Innovation Lab, BJC HealthCare/Washington University School of Medicine, St Louis, Missouri
  • 2Division of Cardiology, Washington University School of Medicine, St Louis, Missouri
JAMA Cardiol. 2021;6(1):48-49. doi:10.1001/jamacardio.2020.4756

Over the past decade, electronic health records (EHRs) have become a primary vehicle for care delivery innovation. One important way that EHRs support this is through clinical decision support (CDS), which efficiently collects, analyzes, and presents digital data to clinical teams to support their care decisions. Done well, CDS can greatly enhance personalization, efficiency, and effectiveness of care delivery. However, CDS has yet to realize its potential. Indeed, clinicians have ignored up to 93% of CDS alerts and are frustrated by excessive rates of false-positive reminders.1 As a result, only two-thirds of CDS are associated with any measurable change in care, and those that do primarily affect process, rather than outcome, measures.2

Add or change institution